^
    BIOMARKER:
    HER-2 overexpression
    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
    Entrez ID:
    2064
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    HER-2 overexpression
    Breast Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    Nanoscale Res Lett - 1wk
    HER-2 overexpression
    Breast Cancer
    ribociclib
    Sensitive
    :
    D
    ESMO-BC 2021 - 1wk
    HER-2 overexpression
    Gastric Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Ogivri (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    Kanjinti (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    Kanjinti (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Kanjinti (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Gastric Cancer
    Herzuma (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    Herzuma (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    HER2 Positive Breast Cancer
    Herzuma (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Negative Breast Cancer
    trastuzumab + lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    lapatinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    trastuzumab/hyaluronidase-oysk
    Sensitive
    :
    A1
    HER-2 overexpression
    Hormone Receptor Positive Breast Cancer
    neratinib
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    Ontruzant (trastuzumab biosimilar)
    Sensitive
    :
    A1
    HER-2 overexpression
    Breast Cancer
    Trazimera (trastuzumab biosimilar)
    Sensitive
    :
    A1
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES